TickerFacts.

InMed Pharmaceuticals Inc. (INM): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2024-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$7.00M
Year ended 2024-06-30
2020-06-30: -$7.42M2021-06-30: -$9.79M2022-06-30: -$15.62M2023-06-30: -$7.44M2024-06-30: -$7.00M-$7.00M
2020-06-30 Free Cash Flow (USD) 2024-06-30
Period endedFree Cash FlowChange YoYSource filing
2024-06-30-$7.00Mn/m2025-09-23, From 2023-07-01
2023-06-30-$7.44Mn/m2024-09-30, From 2022-07-01
2022-06-30-$15.62Mn/m2023-09-29, From 2021-07-01
2021-06-30-$9.79Mn/m2022-09-23, From 2020-07-01
2020-06-30-$7.42Mn/a2021-09-24, From 2019-07-01